NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Health / Surgery
Written by / Agency / Source: Inkwood Research
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

The Growing Geriatric Population Propels the Global Diabetes Drugs Market At A CAGR of 6.50%, 2027 Finds Inkwood Research - According to a new market research report launched by Inkwood Research, The Global Diabetes Drugs Market was valued at nearly $34,296 million in 2018 and is anticipated to reach around $60,435 million by 2027, growing at a CAGR of 6.50%, 2019-2027
The Growing Geriatric Population Propels the Global Diabetes Drugs Market At A CAGR of 6.50%, 2027 Finds Inkwood Research

 

NewswireToday - /newswire/ - Boston, MA, United States, 2019/09/06 - According to a new market research report launched by Inkwood Research, The Global Diabetes Drugs Market was valued at nearly $34,296 million in 2018 and is anticipated to reach around $60,435 million by 2027, growing at a CAGR of 6.50%, 2019-2027.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Browse 33 market data Tables and 22 Figures spread over 190 Pages along with in-depth analysis on Global Diabetes Drugs Market by Diabetes Type (Type 1, Type 2), by Product Class (Insulin (Fast acting insulin, Intermediate-acting insulin, Long-acting insulin), Non-insulin (DPP-4 inhibitor, GLP-1 receptors agonists, SGLT-2 inhibitors, Other non-insulin drugs)), & by Geography.

This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market, by assessing major geographies, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.

Global Diabetes Drugs Market scenario

The increase in the prevalence of diabetes, advances in insulin delivery technology, and the growing elderly population are primarily driving the growth of the Global Diabetes Drugs market.
The Global Diabetes Drugs Market report provides data tables and includes charts and graphs for visual analysis.
Request Free Sample Report for Global Diabetes Drugs Market by diabetes type, product class, and Geography.

Market Segmentation
On the basis of Diabetes Type, Global Diabetes Drugs market is segmented into:
• Type 1
• Type 2
On the basis of Product Class, Global Diabetes Drugs market is segmented into:
• Insulin
oFast acting insulin
oIntermediate-acting insulin
oLong-acting insulin
• Non-insulin
oDPP-4 inhibitor
oGLP-1 receptors agonists
oSGLT-2 inhibitors
oOther non-insulin drugs

Report Highlights
- The report provides a detailed analysis of the current and future market trends, to identify the investment opportunities
- Market forecasts till 2027, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2027

• ASTRAZENECA
• BRAUN MELSUNGEN AG
• NOVO NORDISK A/S
• SANOFI
• DIAVACS INC.
• XOMA CORP.
• ALBIREO PHARMA INC.
• MACROGENICS, INC.
• ASTELLAS PHARMA
• GLAXOSMITHKLINE
• MERCK
• PFIZER
• XERIS PHARMACEUTICALS

Related Reports

Global Antithrombotic Drugs market - Global Antithrombotic Drugs market is predicted to exhibit a CAGR of 6.79% by revenue during the forecast years 2019-2027.

Global Opioids Drug market - Global Opioids Drug market is predicted to exhibit a CAGR of 2.52% by revenue during the forecast years 2019-2027.

Global Hyperphosphatemia Drug market The Global Hyperphosphatemia Drug market is predicted to exhibit a CAGR of 16.13% during the forecast years 2019-2027.

About Inkwood Research

Inkwood Research (inkwoodresearch.com) is a leading market & industry research firm offers you consulting services, syndicated & customized market research reports, business analysis & more.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health / Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Inkwood Research

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health / Surgery articles,
CATCH Visitors via Your Competitors Announcements!


The Growing Geriatric Population Propels the Global Diabetes Drugs Market At A CAGR of 6.50%, 2027 Finds Inkwood Research

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: InkwoodResearch.com 
857-302-4704 sales[.]inkwoodresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Inkwood Research securities in any jurisdiction including any other companies listed or named in this release.

Health / Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Inkwood Research / Company Profile


Read Health / Surgery Most Recent Related Newswires:

Syapse Awarded 2021 Technology Innovation Leadership Award by Frost & Sullivan for Accelerating Real-world Care Delivery
Lumeon Commended by Frost & Sullivan for Enabling Digital Transformation in Healthcare
Payment Integrity Solutions Enable Healthcare Plans to Optimize Processes and Maximize Returns Finds Frost & Sullivan
Menopause to Become the Next Game-changer in the Global Femtech Solutions Industry by 2025 Finds Frost & Sullivan
Innovative MedTech Business Models Will Enable Cost-effective, Decentralized and Patient-centric Care Finds Frost & Sullivan
Data Monetization a Must for MedTech Industry to Evolve Toward Real-World Evidence and Precision Medicine Finds Frost & Sullivan
InterSystems Partners with Cognetivity on Ground-breaking AI Solution for Early Dementia Detection
Humimic Medical, Partners Team Up to Make A Difference in South Carolina COVID Battle
Adoption of HaH Model Surged Eight-fold with the Availability of Advanced Remote Monitoring and Digital Health Solutions Finds Frost & Sullivan
Major Innovation Announcement Planned, SC Life Sciences Conference Shatters Registration Record
South Carolina Life Sciences Conference Adds Top Executives from Microsoft, Alphabet, PhRMA
SC Life Sciences Conference to Feature BIO Global Executive February 16-17
20Lighter Announces Orthopedic Surgery Alliance
Calmerry Introduces Individual, Couples and Family Online Therapy with Licensed Professionals
CoverMyMeds Lauded by Frost & Sullivan for Seamlessly Connecting the Healthcare Network with its Industry-leading ePA Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)